Stockholders Equity and StockBased Compensation (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Dec. 15, 2022 |
Nov. 20, 2023 |
Mar. 25, 2021 |
Mar. 31, 2024 |
Mar. 31, 2023 |
Dec. 31, 2023 |
|
| Outstanding restricted stock awards | 557,688 | 557,688 | ||||
| Common stock, shares, outstanding | 14,189,780 | 13,698,274 | ||||
| Shares of common stock issued | 14,189,780 | 13,698,274 | ||||
| Stock options vested | 542,972 | 498,177 | ||||
| Stock-based compensation expense | $ 456,904 | $ 284,360 | ||||
| Total common stock and all common stock equivalents | 14,745,362 | 14,209,061 | ||||
| Stock options outstanding | 555,582 | 525,903 | 510,787 | |||
| Description related to ATM offerings | On March 25, 2021, the Company filed a shelf registration statement on Form S-3, registering the sale of up to $75.0 million of the Company’s securities, which registration statement was declared effective on April 5, 2021 and was set to expire on April 5, 2024. On April 4, 2023, the Company filed a prospectus supplement pursuant to which the Company could offer and sell shares of its common stock having an aggregate offering price of up to $17.9 million, of which $7.0 million remained available for future share issuances as of March 31, 2024 | |||||
| Shares sale offering price | $ 6,600,000 | |||||
| Maximum sale of securities registered | $ 75,000,000.0 | |||||
| Available for sale Securities [Member] | ||||||
| Shares sold under the ATM | 427,300 | 169,978 | ||||
| Proceeds from shares sold under the ATM | $ 1,200,000 | $ 700,000 | ||||
| Stock issuence cost | $ 100,000 | $ 30,000 | ||||
| Board of Directors Chairman [Member] | ||||||
| Common shares issuances equity grant value | $ 200,000 | $ 240,000 | ||||
| Common shares equity grant price per shares | $ 3.84 | $ 3.97 | ||||
| Additional common shares | 52,085 | 60,456 | ||||
| Consultant [Member] | ||||||
| Stock options granted | 58,309 | 0 | ||||
| 2020 Equity Incentive Plan [Member] | ||||||
| Total number of common stock available for future issuance | 1,800,000 | |||||
| Common stock available for future issuance | 758,672 | |||||
| Common Share Issuances [Member] | ||||||
| Shares of common stock issued | 3,750 | 3,750 | ||||
| Common stock issuance price | $ 4.00 | |||||
| Stock-based compensation expense | $ 15,000 | $ 15,000 | ||||
| Weighted average grant date fair value | $ 4.00 | |||||
| Restricted Stock Award Activity Member | ||||||
| Common stock, shares, outstanding | 557,688 | 557,688 | ||||
| Unrecognized compensation cost related to restricted stock units | $ 2,200,000 | |||||
| Shares of common stock issued | 557,688 | 557,688 | ||||
| Stock-based compensation expense | $ 400,000 | $ 300,000 | ||||
| Weighted-average period | 1 year 10 months 24 days | |||||